Li Kang Biomedical , Ltd. Receivables

Li Kang Biomedical , Ltd. (6242.TWO) currently reports a receivables of $8.5M as of June 2026. That compares with $11M in the prior-year period — down 23.8% year over year. Use the charts on this page to explore Li Kang Biomedical , Ltd.'s receivables history and peer comparisons.

Li Kang Biomedical , Ltd.'s receivables decreased from $11M to $8.5M — a 23.8% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Li Kang Biomedical , Ltd. reported $8.5M in receivables as of June 2026. That compares with $11M in the prior-year period — down 23.8% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $8.5M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Li Kang Biomedical , Ltd., and consider following 6242.TWO for alerts when major investors trade the stock.